Peer Review reports
From: Cost-effectiveness analysis of atezolizumab in advanced triple-negative breast cancer
| Original Submission | ||
|---|---|---|
| 28 Jan 2020 | Submitted | Original manuscript |
| 19 Feb 2020 | Reviewed | Reviewer Report |
| 11 Mar 2020 | Reviewed | Reviewer Report |
| 19 Mar 2020 | Author responded | Author comments - Lee Cheng Phua |
| Resubmission - Version 2 | ||
| 19 Mar 2020 | Submitted | Manuscript version 2 |
| Publishing | ||
| 18 Jun 2020 | Editorially accepted | |
| 24 Jun 2020 | Article published | 10.1186/s12913-020-05445-6 |
You can find further information about peer review here.